Human Breast Milk‐Derived Lactiplantibacillus plantarum WLPL04 as a Functional Probiotic for Preventing Staphylococcus aureus ‐Induced in Periparturient Mice
Journal of Food Science · 2026-05 · 91 (5)
DOI: 10.1111/1750-3841.71129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food Science, online erschienen am 11.05.2026. Verfasst von Wu Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, P. R. China. Hauptthemen laut MEDLINE: Probiotics, Staphylococcus aureus, Lactiplantibacillus plantarum, Mastitis. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
This study evaluated the preventive potential of perinatal supplementation with human breast milk‐derived Lactiplantibacillus plantarum WLPL04‐mCherry to mitigate Staphylococcus aureus infection via prophylactic intervention using a murine mastitis model. Through comprehensive analyses including bacterial enumeration, histopathology, immunohistochemistry, immunofluorescence, and TUNEL staining, we demonstrated that perinatal administration of L. plantarum WLPL04‐mCherry significantly reduced S. aureus loads in mammary glands, mesenteric lymph nodes, and liver. The probiotic alleviated S. aureus ‐induced mammary tissue damage, suppressed neutrophil infiltration and myeloperoxidase activity, downregulated pro‐inflammatory cytokines (IL‐6, IL‐1β, and TNF‐α), and preserved tight junction proteins (Claudin‐1, Occludin, and ZO‐1), thereby reinforcing the blood‐milk barrier and reducing mammary epithelial apoptosis. In vitro co‐culture experiments confirmed its direct antagonistic effect against S. aureus through pH‐dependent growth inhibition. These findings demonstrate that L. plantarum WLPL04‐mCherry prevents S. aureus ‐induced mastitis through multimodal actions including pathogen inhibition, inflammation modulation, barrier protection, and apoptosis reduction. This study highlights L. plantarum WLPL04 as a promising non‐antibiotic preventive agent for perinatal mastitis prophylaxis, offering a sustainable alternative for addressing antibiotic resistance and supporting lactation health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, P. R. China.
- International Institute of Food Innovation Co., Ltd., Nanchang University, Jiangxi, P. R. China.
- Food and Nutritional Science, School of Biological Science, The University of Hong Kong, Hong Kong, P. R. China.
ORCID-Profile: Wu Sun, Nagendra P Shah, Hua Wei
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Sun, W., Zhao, X., Zhong, C., Wang, Y., Xie, K., Tao, X., Shah, N. P., & Wei, H. (2026). Human Breast Milk‐Derived Lactiplantibacillus plantarum WLPL04 as a Functional Probiotic for Preventing Staphylococcus aureus ‐Induced in Periparturient Mice. Journal of Food Science, 91(5). https://doi.org/10.1111/1750-3841.71129
Vancouver
Sun W, Zhao X, Zhong C, Wang Y, Xie K, Tao X, et al. Human Breast Milk‐Derived Lactiplantibacillus plantarum WLPL04 as a Functional Probiotic for Preventing Staphylococcus aureus ‐Induced in Periparturient Mice. Journal of Food Science. 2026;91(5). doi:10.1111/1750-3841.71129
BibTeX
@article{Sun2026,
author = {Sun, Wu and Zhao, Xiangxiang and Zhong, Changcheng and Wang, Yanghong and Xie, Ke and Tao, Xueying and Shah, Nagendra P and Wei, Hua},
title = {Human Breast Milk‐Derived Lactiplantibacillus plantarum WLPL04 as a Functional Probiotic for Preventing Staphylococcus aureus ‐Induced in Periparturient Mice},
journal = {Journal of Food Science},
year = {2026},
volume = {91},
number = {5},
doi = {10.1111/1750-3841.71129}
}
EUVIMED